Growth Metrics

Intelligent Bio Solutions (INBS) Current Assets (2020 - 2024)

Intelligent Bio Solutions has reported Current Assets over the past 5 years, most recently at $11.5 million for Q1 2024.

  • Quarterly results put Current Assets at $11.5 million for Q1 2024, up 160.46% from a year ago — trailing twelve months through Mar 2024 was $11.5 million (up 160.46% YoY), and the annual figure for FY2023 was $3.9 million, down 64.46%.
  • Current Assets for Q1 2024 was $11.5 million at Intelligent Bio Solutions, up from $2.9 million in the prior quarter.
  • Over the last five years, Current Assets for INBS hit a ceiling of $20.0 million in Q4 2020 and a floor of $2.3 million in Q2 2020.
  • Median Current Assets over the past 5 years was $10.9 million (2022), compared with a mean of $10.1 million.
  • Biggest five-year swings in Current Assets: soared 678.1% in 2021 and later tumbled 67.2% in 2023.
  • Intelligent Bio Solutions' Current Assets stood at $20.0 million in 2020, then dropped by 29.46% to $14.1 million in 2021, then tumbled by 54.72% to $6.4 million in 2022, then tumbled by 53.83% to $2.9 million in 2023, then soared by 291.24% to $11.5 million in 2024.
  • The last three reported values for Current Assets were $11.5 million (Q1 2024), $2.9 million (Q4 2023), and $2.7 million (Q3 2023) per Business Quant data.